Kore Private Wealth LLC Neurocrine Biosciences Inc Transaction History

Kore Private Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $27,694 - $38,923	-288 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $24,998 - $34,148	288 New	288 $31,000
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $23,550 - $29,754	-326 Closed	0 $0
Q1 2019 May 16, 2019	BUY	$69.31 - $91.53 $17,327 - $22,882	250 Added 328.95%	326 $29,000
Q4 2018 May 23, 2019	BUY	$68.32 - $124.36 $5,192 - $9,451	76 New	76 $5,000

655

96.7M

316K

300K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.